MedPath
HSA Approval

ECOCORT CREAM

SIN10246P

ECOCORT CREAM

ECOCORT CREAM

October 9, 1998

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

CREAM

**RECOMMENDED DOSAGE :** ECOCORT cream should be applied to the affected area no more than 2 times daily, preferably once in the morning and once in the evening. ECOCORT Cream should not be applied with an occlusive dressings, or to large skin areas of the body. The duration of treatment with ECOCORT Cream should be until the inflammatory symptoms subside but no longer than 2 weeks; after 2 weeks of therapy with ECOCORT Cream, continue therapy as needed with a preparation containing econazole or econazole nitrate alone.

TOPICAL

Medical Information

**INDICATIONS :** ECOCORT CREAM in all its dosages is indicated for the treatment of dermatomycoses complicated by inflammatory and/or pruritic manifestations of skin disorders.

**CONTRAINDICATIONS :** Hypersensitivity to econazole nitrate, triamcinolone acetonide, other corticosteroids or imidazoles, or any component in the base. Topical corticosteroids are contraindicated in most viral infections of the skin, such as vaccinia, varicella, and herpes simplex, also tuberculosis and acne rosacea.

D01AC20

imidazoles/triazoles in combination with corticosteroids

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

TRIAMCINOLONE ACETONIDE

0.1%w/w

Triamcinolone

ECONAZOLE NITRATE

1%w/w

Econazole

Documents

Package Inserts

Ecocort Cream PI.pdf

Approved: September 7, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ECOCORT CREAM - HSA Approval | MedPath